Followers | 145 |
Posts | 27554 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, November 02, 2017 1:08:55 AM
Phase 2 NiCord Data in Allogeneic Bone Marrow Transplant and Preclinical Data for NK Cells to be Presented in Oral Presentations
November 01, 2017 09:00 AM Eastern Daylight Time
JERUSELUM--(BUSINESS WIRE)--Gamida Cell, a leading cellular and immune therapeutics company, today announced that two oral presentations on new data from the company’s pipeline programs will be presented during the 59th Annual Meeting of the American Society for Hematology (ASH).
The oral presentations will highlight safety and efficacy data for a completed phase 2 study of the company’s lead clinical asset, NiCord, as a single cord blood graft, and proof-of-concept data for the advancement of natural killer cells (NK cells) as an immunotherapeutic modality for patients with cancer. These abstracts are now available on the ASH conference website.
Oral Presentations
NiCord Single Unit Expanded Umbilical Cord Blood Transplantation (UCBT): Final Results of a Multicenter Phase I/ II Trial
Date & Time: Monday, December 11, 2017 at 4:30 p.m. ET
Session Name: Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era
Abstract Number: 847
Location: Georgia World Congress Center, Building C, Level 2, Room C202-204
Enhanced In Vivo Persistence and Proliferation of NK Cells Expanded in Culture with the Small Molecule Nicotinamide: Development of a Clinical-Applicable Method for NK Expansion
Date & Time: Monday, December 11, 2017 at 11:00 a.m. ET
Session Name: Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture
Abstract Number: 657
Location: Georgia World Congress Center, Building B, Level 2, Room B216-217
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM